In the same research, they also reported that Galectin-3 and Cav-1 were required for RhoA GTPase activation and knocking down of either Galectin-3 or Cav-1 significantly reduced the migration of differentiated thyroid cancer cells. This evidence concerns the gene CAV1 and thyroid cancer.